Biomarker discovery using high-dimensional lipid analysis

Current Opinion in Lipidology

Volumn 18, Issue 2, 2007, Pages 181-186

  Wiest, Michelle M ^a   Watkins, Steven M ^a  

^a Lipomics Technologies Inc   (United States)

Author keywords

Biomarkers; Data reduction; Lipid analysis; Lipidomics; Metabolomics

Indexed keywords

ACYLCARNITINE; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; ICOSANOID; LIPID; PROSTAGLANDIN SYNTHASE; SPHINGOLIPID;

CHEMICAL STRUCTURE; CHROMATOGRAPHY; DATA ANALYSIS; EXERCISE TEST; HEART MUSCLE ISCHEMIA; HUMAN; LIPID ANALYSIS; LIPID METABOLISM; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TANDEM MASS SPECTROMETRY;

AUTOMATIC DATA PROCESSING; BIOLOGICAL MARKERS; HUMANS; LIPIDS; RESEARCH; SAMPLE SIZE;

EID: 33947148718     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3280895d82     Document Type: Review

References (41)

1. Lindsay MA. Target discovery. Nat Rev: Drug Discovery 2003; 2:831-838.
2. Sabatine MS, Liu E, Morrow DA, et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 2005; 112:3868-3875. • A wonderful example of thoughtful experimental design and data analysis using metabolomics to identify novel markers of myocardial ischemia.
3. Isaac G, Jeannotte R, Esch SW, Welti R. New mass-spectrometry-based strategies for lipids. Genet Eng (NY) 2007; 28:129-157.
4. Morris M, Watkins SM. Focused metabolomic profiling in the drug development process: advances from lipid profiling. Curr Opin Chem Biol 2005; 4:407-412.
5. Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov 2005; 4:594-610.
6. Fahy E, Subramaniam S, Brown HA, et al. A comprehensive classification system for lipids. J Lipid Res 2005; 46:839-861; E-pub 16 February 2005.
7. Hong S, Gronert K, Devchand PR, et al. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in antiinflammation. J Biol Chem 2003; 278:14677-14687.
8. Tan B, Bradshaw HB, Rimmerman N, et al. Targeted lipidomics: discovery of new fatty acyl amides. AAPS J 2006; 8:E461-E465.
9. Han X, Gross RW. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 2005; 24:367-412.
10. Han X, Gross RW. Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes. Expert Rev Proteomics 2005; 2:253-264.
11. Lee SH, Williams MV, DuBois RN, Blair IA. Targeted lipidomics using electron capture atmospheric pressure chemical ionization mass spectrometry. Rapid Commun Mass Spectrom 2003; 17:2168-2176.
12. Kita Y, Takahashi T, Uozumi N, Shimizu T. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversedphase liquid chromatography-tandem mass spectrometry. Anal Biochem 2005; 342:134-143.
13. Newman JW, Watanabe T, Hammock BD. The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS. J Lipid Res 2002; 43:1563-1578.
14. Moran FM, Hendrickx AG, Shideler S, et al. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on fatty acid availability and neural tube formation in cynomolgus macaque, Macaca fascicularis. Birth Defects Res B Dev Reprod Toxicol 2004; 71:37-46.
15. Watkins SM, Zhu X, Zeisel SH. Phosphatidylethanolamine-N- methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice. J Nutr 2003; 133:3386-3391.
16. Watkins SM, Reifsnyder PR, Pan HJ, et al. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J Lipid Res 2002; 43:1809-1817.
17. Schiller J, Suss R, Arnhold J, et al. Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research. Prog Lipid Res 2004; 43:449-488.
18. Sullards MC, Merrill AH. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Sci STKE 2001; 67:pl1.
19. Bielawski J, Szulc ZM, Hannun YA, Bielawska A. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 2006; 39:82-91.
20. Mueller P, Schulze A, Schindler I, et al. Validation of an ESI-MS/MS screening method for acylcarnitine profiling in urine specimens of neonates, children, adolescents and adults. Clin Chim Acta 2003; 327:47-57.
21. Bijlsma S, Bobeldijk I, Verheij ER, et al. Large-scale human metabolomics studies: a strategy for data (pre) processing and validation. Anal Chem 2006; 78:567-574. •• An excellent paper illustrating a practical protocol for processing metabolomics data from a large sample set.
22. Westgard JO. Basic QC practices: training in statistical quality control for healthcare laboratories. 2nd ed. Madison: Westgard QC, Inc.; 2002.
23. Perco P, Rapberger R, Siehs C, et al. Transforming omics data into context: bioinformatics on genomics and proteomics raw data. Electrophoresis 2006; 27:2659-2675. • A good review of computational procedures for the analysis of genomic and proteomic data that is also relevant to metabolomic data.
24. Yasui Y, Pepe M, Thompson ML, et al. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics 2003; 4:449-463.
25. Watkins SM, Reifsnyder PR, Pan H, et al. Lipid metabolome-wide effects of the PPARγ agonist rosiglitazone. J Lipid Res 2002; 43:1809-1817.
26. Beigneux AP, Vergnes L, Qiao X, et al. Agpat6 - a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium. J Lipid Res 2006; 47:734-744.
27. Troyanskaya O, Cantor M, Sherlock G, et al. Missing value estimation methods for DNA microarrays. Bioinformatics 2001; 17:520-525.
28. Lubin JH, Colt JS, Camann D, et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect 2004; 112:1691-1696.
29. Fletcher D, Mackensie D, Villouta E. Modelling skewed data with many zeros: a simple approach combining ordinary and logistic regression. Environmen Ecol Stat 2005; 12:45-54. • A paper introducing a method of analyzing data with missing values.
30. Meleth S, Deshane J, Kim H. The case for well-conducted experiments to validate statistical protocols for 2D gels: different pre-processing = different lists of significant proteins. BMC Biotechnol 2005; 5:7. • A paper examining the effects of data pre-processing on 2D gel electrophoresis. Results indicate statistical results aredependent upon the methodof pre-processing.
31. Johnson RA, Wichern DW. Applied multivariate statistical analysis. 5th ed. Upper Saddle River, NJ: Prentice Hall; 2002. pp. 426-452.
32. Garthwaite PH. An interpretation of partial least squares. JASA 1994; 89:122-127.
33. Nguyen DV, Rocke DM. Tumor classification by partial least squares using microarray gene expression data. Bioinformatics 2002; 18:39-50.
34. Pan W. On the use of permutation in and the performance of a class of nonparametric methods to detect differential gene expression. Bioinformatics 2003; 19:1333-1340.
35. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995; 57:289-300.
36. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545-15550. •• An introduction to gene set enrichment analysis. This paper illustrates how incorporating biological knowledge into data analysis results in an increased ability to detect relevant changes in gene expression.
37. Berriz GF, King OD, Bryant B, et al. Characterizing gene sets with funcassociate. Bioinformatics 2003; 19:2502-2504.
38. Press SJ, Wilson S. Choosing between logistic regression and discriminant analysis. JASA 1978; 73:699-705.
39. Man MZ, Dyson G, Johnson K, et al. Evaluating methods for classifying expression data. J Biopharm Stat 2004; 14:1065-1084.
40. Efron B. Estimating the error rate of a prediction rule: improvement on crossvalidation. JASA 1983; 78:316-331.
41. Stone M. Cross-validatory choice and assessment of statistical predictors. J R Stat Soc 1974; 36:111-147.